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ith phosphodiesterase/phospho-triesterase, and by gel
ltration of molecular mass.
Results: The enzyme:
was widely distriibuted in animal. plant tissues, and in
microorganisms.
was associated with poliovirus, inﬂuenza virus, brome
mosaic virus, avian virus, southern
bean mosaic virus and mouse retrovirus
6-azauridine inhibits enzyme activity and the infectivity
of inﬂuenza virus on HeLa cells.
Conclusion: - An evolutionary signiﬁcant enzyme.
We speculate the enzyme is associated with the following
viral families: Flaviridae, Herpesviridae, Coronaviridae,
Picornaviridae, Papillomaviridae and Nipahviridae to
name a few.
6-azauridine inhibits on soluble form and virus bound
enzymes (Fig.3).
This investigation has been carried out on/off over two
decades in Department of Genetics, UW-Madison, US.
This presentation is dedicated to remember the late pro-
fessor Oliver E. Nelson, member of National Academy of
Science.
We are anxiously looking forward to collaborate with any
laboratory, institution, organization and industry in world-
wide to demonstrate quickly and precisely the existence
of this enzyme on surface of virions,i.e; mump, smallpox,
yellow fever, rubies, rubella, particularly HIV and H1N1
viruses and many others. Since we believe undoubedtly
that the results will contribute to understanding the pre-
vention, treatment and infectivity of viruses
6-Azauridine inhibits soluble enzyme activity
oi:10.1016/j.ijid.2010.02.639
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nfectious mononucleosis in Albanian children
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Background: To study some of the epidemiological data,
linical manifestations, diagnosis and treatment of the chil-
ren hospitalized in the pediatrics infectious diseases ward.
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Methods: In the study are included 47 children from 1-
years hospitalized in Pediatrics Infectious Diseases Ward
uring 2003-2008. From the childrens cards we studied
mportant data as: distribution according to age group,
ender, residence, season and important clinical mani-
estation such as fever, fatigue, pharyngitis, generalized
ymphadenopathy and splenomegaly. Conﬁrmation of the
iagnosis is done by speciﬁc serological tests (antibody anti-
BV).
Results: According to age group 1-4 yr 30 cases (64%), 4-8
r 11 cases (23%), 8-14 yr 6 cases (13%); gender male 35 cases
74%), female 12 cases (26%); residence city 36 cases (76%),
illage 11 cases (24%); season spring 12 cases (25%), summer
cases (13%), autumn 11 cases (23%), winter 18 cases (39%).
linical manifestations: fever 47 cases (100%), Pharyngitis
hyperemic exudativ) 47 cases (100%), lymphadenopathy 37
ases (73%), cervicolatheral predominantly 25 cases (68%),
plenomegaly 15 cases (32%), hepatomegaly 7 cases (15%). In
5% of cases was found leucocitosis (10000-26000 cel/mm+),
typical lymphocytosis in peripheral blood (>10%), in 37
ases (79%) and elevated SGPT. Speciﬁc serological tests
or anti body anti-EBV (anti-VCA-IgG and anti-VCA-IgM) were
ositive in all cases.
12 cases (25%) resulted with pulmonary infections, 5
ases (10%) with urinary tract infections and 3 cases (6%)
ith biliary tract infection.
Conclusion: Infectious mononucleosis is a clinical syn-
rome caused by Epstein-Bar virus which is not rare and
ust be considered in pediatric population. This syn-
rome expressed clinically by the thriad; pharyngitis,
ymphadenopathy and splenomegaly must make us suspect
he diagnosis of infectious mononucleosis which is conﬁrmed
y speciﬁc serological tests. Therapy with corticosteroids for
hort periods (<2 weeks) is indicated only in complications
s airway obstruction, massive splenomegaly, myocardi-
is, hemolytic anemia, seizure, meningitis. Therapy with
cyclovir decreases viral replication and oropharyngeal
hedding but does not reduce the severity or durarion of
ymptoms.
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ymptomatic, long-term Parvovirus B19 infection in oth-
rwise healthy adults
. Manfredi
University of Bologna, Bologna, Italy
Background: Parvoviridae are part of air-, parenteral- and
erinatal-transmitted ubiquitous viruses, whose associated
igns and symptoms strongly depend on patient’s age and
mmune defence.
Methods: All cases of symptomatic Parvovirus B19 infec-
ion in otherwise healthy adults which came to our attention
ince spring 2006 were prospectively investigated and fol-
owedup.
Results: In a 21-month period, 11 patients (7 females
nd 4 males), with a mean age of 36.9 (range 27-46) years
ith a symptomatic Parvovirus B19 infection were recorded
nd followed-up. Intrafamiliar exposure and occupational
health care) exposure were identiﬁed in two cases each.
